674 related articles for article (PubMed ID: 15841673)
1. [The small airway inflammation of asthmatic patients who have used dry powder type inhaled steroid for moderate-long term evaluated by induced sputum and the efficacy of HFA-BDP (QVAR) inhalation].
Ohbayashi H
Arerugi; 2005 Jan; 54(1):24-35. PubMed ID: 15841673
[TBL] [Abstract][Full Text] [Related]
2. One-year evaluation of the preventative effect of hydrofluoroalkane-beclomethasone dipropionate on eosinophilic inflammation of asthmatic peripheral airways.
Ohbayashi H
Respiration; 2007; 74(2):146-53. PubMed ID: 16804291
[TBL] [Abstract][Full Text] [Related]
3. [A multicenter, open-label, randomized comparison of suppressive effects on asthmatic inflammation of lower airways and improved effects on health-related QOL between HFA-BDP and fluticasone propionate].
Ohbayashi H; Adachi M; Ichinose M; Ohta K; Kokubu F; Sano Y; Tamura G; Tohda Y; Hirata K; Yasuba H
Arerugi; 2007 Jun; 56(6):577-86. PubMed ID: 17615501
[TBL] [Abstract][Full Text] [Related]
4. Hydrofluoroalkane-beclomethasone dipropionate effectively improves airway eosinophilic inflammation including the distal airways of patients with mild to moderate persistent asthma as compared with fluticasone propionate in a randomized open double-cross study.
Ohbayashi H; Adachi M
Allergol Int; 2008 Sep; 57(3):231-9. PubMed ID: 18493166
[TBL] [Abstract][Full Text] [Related]
5. [An evaluation of the acceptance of budesonide turbuhaler by older Japanese patients with bronchial asthma when changed from fluticasone propionate (FP) or beclomethasone dipropionate (BDP)].
Ohbayashi H; Yamase H
Arerugi; 2003 Jan; 52(1):31-8. PubMed ID: 12598720
[TBL] [Abstract][Full Text] [Related]
6. Benefits of induced sputum for the evaluation of therapeutic efficacy in patients with bronchial asthma.
Ohnishi H; Maeda H; Nishimura Y; Yokoyama M
Kobe J Med Sci; 1998 Aug; 44(4):149-61. PubMed ID: 10352494
[TBL] [Abstract][Full Text] [Related]
7. [A case of severe persistent bronchial asthma who showed significant improvement by switching to hfa-bdp, with reducing the dosage of oral steroids].
Ohbayashi H
Arerugi; 2005 Nov; 54(11):1294-301. PubMed ID: 16407676
[TBL] [Abstract][Full Text] [Related]
8. Effects of hydrofluoroalkane and dry powder-formulated corticosteroids on sputum inflammatory markers in asthmatic patients.
Hauber H; Taha R; Bergeron C; Migounov V; Hamid Q; Olivenstein R
Can Respir J; 2006 Mar; 13(2):73-8. PubMed ID: 16550263
[TBL] [Abstract][Full Text] [Related]
9. Salmeterol decreases eosinophilic cationic protein and rescue medication in patients inhaling beclomethasone dipropionate: preliminary study in mild and moderate asthma in Trinidad, West Indies.
Pinto Pereira LM; Clement Y; Rouse J; Matthew J; Asgarali Z; Ramoutar D; Teelucksingh S
Int J Clin Pharmacol Res; 2003; 23(2-3):69-74. PubMed ID: 15025036
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of HFA-beclomethasone dipropionate extra-fine aerosol (800 microg day(-1)) versus HFA-fluticasone propionate (1000 microg day(-1)) in patients with asthma.
Aubier M; Wettenger R; Gans SJ
Respir Med; 2001 Mar; 95(3):212-20. PubMed ID: 11266239
[TBL] [Abstract][Full Text] [Related]
11. Effects of different anti-asthmatic agents on induced sputum and eosinophil cationic protein in mild asthmatics.
Basyigit I; Yildiz F; Kacar Ozkara S; Boyaci H; Ilgazli A; Ozkarakas O
Respirology; 2004 Nov; 9(4):514-20. PubMed ID: 15612964
[TBL] [Abstract][Full Text] [Related]
12. Extrafine beclomethasone dipropionate breath-actuated inhaler (400 micrograms/day) versus budesonide dry powder inhaler (800 micrograms/day) in asthma.
Reichel W; Dahl R; Ringdal N; Zetterstrom O; van den Elshout FJ; Laitinen LA
Int J Clin Pract; 2001 Mar; 55(2):100-6. PubMed ID: 11321849
[TBL] [Abstract][Full Text] [Related]
13. Induced sputum and bronchoalveolar lavage as tools for evaluating the effects of inhaled corticosteroids in patients with asthma.
Nocker RE; Out TA; Weller FR; de Riemer MJ; Jansen HM; van der Zee JS
J Lab Clin Med; 2000 Jul; 136(1):39-49. PubMed ID: 10882226
[TBL] [Abstract][Full Text] [Related]
14. [The relationship between sputum eosinophils and responses to treatment of inhaled glucocorticoids in patients with persistent asthma].
Jiang YW; Sun YC; Zhou QT; Gai XY; Cao WL; Yao WZ
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):447-51. PubMed ID: 17673020
[TBL] [Abstract][Full Text] [Related]
15. Comparison of hydrofluoroalkane-beclomethasone dipropionate Autohaler with budesonide Turbuhaler in asthma control.
Worth H; Muir JF; Pieters WR
Respiration; 2001; 68(5):517-26. PubMed ID: 11694816
[TBL] [Abstract][Full Text] [Related]
16. Safety and application of induced sputum analysis in childhood asthma.
Covar RA; Spahn JD; Martin RJ; Silkoff PE; Sundstrom DA; Murphy J; Szefler SJ
J Allergy Clin Immunol; 2004 Sep; 114(3):575-82. PubMed ID: 15356559
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of beclomethasone dipropionate HFA 200 microg once daily in chronic obstructive pulmonary disease and bronchial asthma.
Tatsis G; Kotsifas K; Filaditaki V; Makrantoni G; Boulia S
J Int Med Res; 2007; 35(3):361-73. PubMed ID: 17593865
[TBL] [Abstract][Full Text] [Related]
18. [Effect of FP inhalation and airway inflammation assessed by ECP in asthma].
Haneda H; Koizumi M
Nihon Kokyuki Gakkai Zasshi; 2001 Jun; 39(6):394-8. PubMed ID: 11530386
[TBL] [Abstract][Full Text] [Related]
19. Ease of handling and clinical efficacy of fluticasone propionate Accuhaler/Diskus inhaler compared with the Turbohaler inhaler in paediatric patients. UK Study Group.
Williams J; Richards KA
Br J Clin Pract; 1997; 51(3):147-53. PubMed ID: 9293055
[TBL] [Abstract][Full Text] [Related]
20. [Eosinophil count in induced sputum samples as a marker of airway inflammation and adequacy of corticosteroid inhalation treatment in asthmatic patients].
Tomii K; Matsumura Y; Taguchi Y; Oida K; Kobash Y
Nihon Kokyuki Gakkai Zasshi; 1998 Feb; 36(2):138-43. PubMed ID: 9617140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
